Feasibility of the Menstrual Cup for VVF (FMCVVF)
Primary Purpose
Vaginal Fistula, Vesico Vaginal Fistula, Obstetric; Injury
Status
Unknown status
Phase
Not Applicable
Locations
Ghana
Study Type
Interventional
Intervention
Menstrual Cup
Sponsored by
About this trial
This is an interventional treatment trial for Vaginal Fistula focused on measuring obstetric fistula, vesicovaginal fistula, menstrual cup, pad test, non-surgical management, feasibility, acceptability, innovation, coping, incontinence
Eligibility Criteria
Inclusion Criteria:
- Patient seeking surgical repair for VVF
- VVF confirmed by gynecologic examination
- Adequate vaginal capacity to accommodate the menstrual cup
- Fistula high in vagina (determined at gynecologic examination)
- Willingness to insert and remove the device by one's self
Exclusion Criteria:
- Technically difficult to insert and or remove the menstrual cup (eg severely scarred vagina)
- Unable or unwilling to learn to insert and remove the menstrual cup
- Patient who declines consent or is incapable of consent
- Presence of rectovaginal fistula (RVF) or combined RVF and VVF
- Fistula low in the vagina precluding collection of urine by the menstrual cup
Sites / Locations
- Mercy Women's Catholic HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intervention (Menstrual Cup)
Arm Description
The menstrual cup is a 100% silicone, flexible reservoir cup that, when inserted correctly in the vagina, is sanitary and efficacious in preventing leakage of menstrual blood and in eliminating odor.
Outcomes
Primary Outcome Measures
Volume of urinary leakage (in ml)
Measured by 2-hr pad test
Secondary Outcome Measures
Acceptability of the menstrual cup
Using a Likert scale with values ranging from 1-5, acceptability is reported based on ease of use, insertion, wearing, removal, and cleaning. A summarizing acceptability scale is not reported.
Adverse events
Erythema, edema/induration, erosion, bleeding assessed by clinical exam
Rate of enrollment through study completion
Number of individuals who enroll out of the total number of individuals screened
Rate of consent through study completion
Number of individuals who complete the consent form out of the total number of screened individuals meeting all other inclusion and exclusion criteria
Perceived assessment of leakage with use of the menstrual cup
Proportion of participants that perceive a reduction in leakage (either marked or slight) with use of the menstrual cup compared to their usual strategy for fistula management. This question uses likert-type responses to note whether the respondent perceives their urine leakage markedly improved, slightly improved, no change, slightly worse, or markedly worse.
Full Information
NCT ID
NCT03414060
First Posted
January 19, 2018
Last Updated
October 17, 2018
Sponsor
University of Ghana Medical School
Collaborators
New York University College of Global Public Health, NYU Langone Health, Korle-Bu Teaching Hospital, Accra, Ghana
1. Study Identification
Unique Protocol Identification Number
NCT03414060
Brief Title
Feasibility of the Menstrual Cup for VVF
Acronym
FMCVVF
Official Title
Feasibility of the Menstrual Cup for Non-Surgical Management of VVF Among Women Seeking Care at a Health Facility in Ghana
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Unknown status
Study Start Date
August 8, 2016 (Actual)
Primary Completion Date
December 2, 2016 (Actual)
Study Completion Date
January 25, 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Ghana Medical School
Collaborators
New York University College of Global Public Health, NYU Langone Health, Korle-Bu Teaching Hospital, Accra, Ghana
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study examines the feasibility and acceptability of the vaginal menstrual cup for short-term management of vesicovaginal fistula (VVF) among 11 women seeking treatment at a health facility in Ghana. The repeated measures design utilizes a 2-hr pad test to compare urinary leakage with and without the insertable cup, a questionnaire on acceptability and perceived effect is administered and a clinical exam is completed. Subsequently, semi-structured interviews will be carried out with up to 24 additional women seeking treatment at a health facility in Ghana. Interviews will cover women's experiences of living with fistula, including strategies for coping with urinary incontinence and resulting stigma, as well as user acceptability to the intervention.
Detailed Description
Vesicovaginal fistula (VVF) is a debilitating maternal morbidity that largely results from complications of prolonged, obstructed labor when the trapped fetal head applies direct pressure to pelvic/vaginal tissues and causes widespread ischemia, tissue necrosis, and subsequent extensive fistula formation. Women living with VVF, the most common anatomical presentation of obstetric fistula, experience urinary incontinence which causes discomfort, malodor, and skin infection, as well as social and psychological consequences that increase their vulnerability to the negative effects of stigma and reduce their quality of life.
Traditional management requires surgical repair; however, many women either do not have access to surgery, or access is delayed due to various individual, social, or structural barriers. Non-surgical management, previously explored with non-invasive techniques for residual urinary incontinence, has been under-examined for fistula-related urinary incontinence. The menstrual cup may be a useful option for non-surgical management of obstetric fistula. Clinical and programmatic reports suggest a potential translation of the menstrual cup for collection or control of urine leakage in women with VVF; however, evidence has not been collected and examined systematically within a population in an endemic setting.
While surgical management of fistula remains the gold standard in treatment, research on non-surgical therapies is necessary.Therefore, this study aims to assess the feasibility (including efficacy, safety, and acceptability among users) of using the menstrual cup over a short period among women seeking care for VVF in a clinical setting and, unlike prior reports, includes standardized measures of leakage and prioritizes user perspectives.
A repeated measures design compared volume of leakage with the and without the cup to baseline leakage via a 2-hr pad test among women with VVF seeking surgical repair at a health facility in Ghana. A questionnaire was later administered followed by a physical exam. A paired t-test was used to analyze effect.
Beginning October 2018, semi-structured interviews with up to 24 women seeking treatment at a health facility in Ghana will be carried out on women's experience with fistula, including strategies for coping with urinary incontinence and resulting stigma, as well as their acceptability to the insertable device. This mixed methods approach is necessary to compare quantitative results and qualitative findings regarding what women are already doing to cope with incontinence and stigma, and their acceptability to this device to manage leaking and support coping.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vaginal Fistula, Vesico Vaginal Fistula, Obstetric; Injury
Keywords
obstetric fistula, vesicovaginal fistula, menstrual cup, pad test, non-surgical management, feasibility, acceptability, innovation, coping, incontinence
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
repeated measures
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention (Menstrual Cup)
Arm Type
Experimental
Arm Description
The menstrual cup is a 100% silicone, flexible reservoir cup that, when inserted correctly in the vagina, is sanitary and efficacious in preventing leakage of menstrual blood and in eliminating odor.
Intervention Type
Device
Intervention Name(s)
Menstrual Cup
Primary Outcome Measure Information:
Title
Volume of urinary leakage (in ml)
Description
Measured by 2-hr pad test
Time Frame
Over 2 hours
Secondary Outcome Measure Information:
Title
Acceptability of the menstrual cup
Description
Using a Likert scale with values ranging from 1-5, acceptability is reported based on ease of use, insertion, wearing, removal, and cleaning. A summarizing acceptability scale is not reported.
Time Frame
Over 2 hours
Title
Adverse events
Description
Erythema, edema/induration, erosion, bleeding assessed by clinical exam
Time Frame
Over 2 hours
Title
Rate of enrollment through study completion
Description
Number of individuals who enroll out of the total number of individuals screened
Time Frame
through study completion, an average of 1 year
Title
Rate of consent through study completion
Description
Number of individuals who complete the consent form out of the total number of screened individuals meeting all other inclusion and exclusion criteria
Time Frame
through study completion, an average of 1 year
Title
Perceived assessment of leakage with use of the menstrual cup
Description
Proportion of participants that perceive a reduction in leakage (either marked or slight) with use of the menstrual cup compared to their usual strategy for fistula management. This question uses likert-type responses to note whether the respondent perceives their urine leakage markedly improved, slightly improved, no change, slightly worse, or markedly worse.
Time Frame
After 1 hour of use
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient seeking surgical repair for VVF
VVF confirmed by gynecologic examination
Adequate vaginal capacity to accommodate the menstrual cup
Fistula high in vagina (determined at gynecologic examination)
Willingness to insert and remove the device by one's self
Exclusion Criteria:
Technically difficult to insert and or remove the menstrual cup (eg severely scarred vagina)
Unable or unwilling to learn to insert and remove the menstrual cup
Patient who declines consent or is incapable of consent
Presence of rectovaginal fistula (RVF) or combined RVF and VVF
Fistula low in the vagina precluding collection of urine by the menstrual cup
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nessa Ryan, MPH, MSCI
Email
ryann01@nyu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gabriel YK Ganyaglo, MPH, MSCI
Organizational Affiliation
Korle-Bu Teaching Hospital, Accra, Ghana
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mercy Women's Catholic Hospital
City
Mankesim
State/Province
Central Region
Country
Ghana
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nessa Ryan, MPH, MSCI
Phone
+1.704.806.2062
Email
ryann01@nyu.edu
First Name & Middle Initial & Last Name & Degree
Gabriel Ganyaglo, MD
Phone
+1.704.806.2062
Email
gganyaglo@hotmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Feasibility of the Menstrual Cup for VVF
We'll reach out to this number within 24 hrs